Antimicrobial resistance (AMR) is a global health crisis, threatening to undo decades of medical progress and plunge us into a post-antibiotic era where even minor infections could prove fatal. This silent pandemic demands immediate and decisive action from all stakeholders before we are left vulnerable to previously treatable infections. The alarming rise of drug-resistant infections, coupled with a stagnant pipeline of new treatment options, paints a grim picture for the future of healthcare.
The statistics underscore the urgency of this situation: the WHO estimates that by 2050, AMR could claim a staggering 10 million lives annually. This exponential rise in AMR translates to increased mortality rates, prolonged hospital stays, and a significant burden on healthcare systems globally, pushing them towards a breaking point.
